![](/us.svg)
Trademark: 90072211
Status Date
Monday, March 11, 2024
Filing Date
Friday, July 24, 2020
Published for Opposition
Tuesday, December 15, 2020
Abandoned Date
Monday, March 11, 2024
5 Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy
Mar 11, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 11, 2024
Abandonment - No Use Statement Filed
Aug 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2023
Sou Extension 5 Granted
Aug 8, 2023
Sou Extension 5 Filed
Aug 15, 2023
Case Assigned To Intent To Use Paralegal
Aug 8, 2023
Sou Teas Extension Received
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2023
Sou Extension 4 Granted
Feb 6, 2023
Sou Extension 4 Filed
Feb 6, 2023
Sou Teas Extension Received
Aug 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2022
Sou Extension 3 Granted
Aug 5, 2022
Sou Extension 3 Filed
Aug 5, 2022
Sou Teas Extension Received
Feb 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 4, 2022
Sou Extension 2 Granted
Feb 4, 2022
Sou Extension 2 Filed
Feb 4, 2022
Sou Teas Extension Received
Jul 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2021
Sou Extension 1 Granted
Jul 27, 2021
Sou Extension 1 Filed
Jul 27, 2021
Sou Teas Extension Received
Feb 9, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 15, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 15, 2020
Published For Opposition
Nov 25, 2020
Notification Of Notice Of Publication E-Mailed
Nov 12, 2020
Approved For Pub - Principal Register
Nov 10, 2020
Assigned To Examiner
Aug 21, 2020
New Application Office Supplied Data Entered
Jul 28, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24